Ligand Pharmaceuticals | Kortsiktig Gjeld



Current Liabilities Endring Dato
Amgen USD 23.1B 2.79B 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Baxter International USD 6.51B 311M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
MacroGenics USD 59.31M 1.4M 2024-09
Merck USD 28.42B 1.17B 2024-12
Pacira USD 309.92M 3.52M 2024-12
Pfizer USD 43B 216M 2024-12
Veracyte USD 78.63M 8.32M 2024-12



Ligand Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.